Skip to main content

Fangzhou Wins Tencent Health ‘AI-Powered Future Award’ as MaaS Platform Drives AI Chronic Care

Written by Customer Service on . Posted in Public Companies.

SHANGHAI, Feb. 09, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leader in AI-driven Internet healthcare solutions, has won the “AI-Powered Future Award” at a high-level industry forum hosted by Tencent Health, underscoring its pioneering efforts in the field of “AI + Chronic Disease Services” and its strong leadership in the digital transformation of the healthcare sector.

The award was presented at the “T-Inspire CIO Private Forum,” organized by Tencent Health to convene senior executives and technology leaders from across the life sciences, pharmaceutical manufacturing and healthcare technology sectors.

Fangzhou Wins Tencent Health “AI-Powered Future Award”

Fangzhou Wins Tencent Health “AI-Powered Future Award”

As one of China’s leading “AI-enabled chronic care” platforms, Fangzhou has positioned technology as a core growth driver. In 2025, the Company completed a strategic upgrade of its H2H (Hospital-to-Home) model into an “AI + H2H” smart healthcare ecosystem. The model is built on long-term, trust-based doctor–patient relationships, which the company views as a key differentiator in chronic disease management.

Alongside this upgrade, Fangzhou has expanded its MaaS (Medicine as a Service) framework, integrating its solid foundation of patient trust with robust service delivery capabilities, translating “patient-centric care” into actionable, closed-loop, and scalable chronic disease management solutions. By doing so, Fangzhou is spearheading the industry’s transition from traditional pharmaceutical distribution to an intelligent healthcare service system. This shift marks a qualitative leap for chronic disease care — evolving from a reactive, one-way response model into a proactive, interactive, and collaborative partnership between patients and healthcare providers.

The Company’s collaboration with Tencent Health has played a central role in this process. Fangzhou contributes deep domain knowledge and real-world insights from chronic care scenarios, while Tencent provides cloud computing, data and AI infrastructure. Together, the partners have established a closed loop from technology validation to large-scale deployment, offering a replicable blueprint for intelligent chronic care service.

Fangzhou said its AI-driven model has helped overcome traditional constraints of time and geography in healthcare delivery, expanding post-hospital care coverage while improving service efficiency through algorithm-driven workflows. These capabilities have supported sustained growth in user engagement and platform activity, reflecting strong user retention and long-term service value.

The award comes against the backdrop of the Company’s improved financial performance. The company recently issued a positive profit alert with forecasted 2025 revenue of RMB 3.5 billion to RMB 3.55 billion, representing ~30% year-on-year growth, highlighting the strong performance of its chronic care model.

Looking ahead, Fangzhou will continue to strengthen its MaaS system, deepen AI integration across chronic disease services, and broaden access to professional, technology-enabled care while reinforcing its position as a key player in the country’s healthcare digitization drive.

About Fangzhou Inc.
Fangzhou Inc. (HKEX: 06086) is China’s leading online chronic disease management platform, serving 52.8 million registered users and 229,000 physicians (as of June 30, 2025). The Company specializes in delivering tailored medical care and AI-enabled precision medicine solutions. For more information, visit https://investors.jianke.com.

Media Contact
For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements.

A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/87935ce9-eea5-456f-bb01-a06951749c93

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.